Our observation that LRG1 affects endothelial junctional molecule expression is also consistent with a reduction in NG2 expression, as NG2 has been shown to enhance junction formation [56], and promote the expression of CD31 in tumour-associated vessels [55]. The gene discussed is CSPG4; the disease is neoplasm.